< Previous2032nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE Saturday, 23 April 2022 IS0512:15 - 13:15Integrated Symposium Hall Q Leveraging the host response to acute infection to create new diagnostic and prognostic tools ChairTanya Gottlieb (Haifa, Israel) ESCMID-appointed chairGiovanni Delogu (Rome, Italy) I02012:15Welcome and introduction Giovanni Delogu (Rome, Italy) Tanya Gottlieb (Haifa, Israel) I02112:20Ending antibiotic prescriptions for viral respiratory infection Louis Bont (Utrecht, Netherlands) I02212:40Utilizing and studying host biomarkers in low resource setting Sabine Dittrich (Geneva, Switzerland) I02313:00Moderated Q&A/Discussion Giovanni Delogu (Rome, Italy) Tanya Gottlieb (Haifa, Israel) Co-organised with: MeMed21 INTEGRATED SYMPOSIA 32nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE Saturday, 23 April 2022 IS0613:30 - 15:00 Integrated SymposiumHall L Role of monoclonal antibodies (mAbs) in the evolution of early treatment in COVID-19 ChairKrystal Evans (London, United Kingdom) ESCMID-appointed chairAruna Subramanian (Stanford, United States) I02413:30Welcome and introduction Krystal Evans (London, United Kingdom) Aruna Subramanian (Stanford, United States) I02513:40Re-appraisal of unmet needs in early treatment Marta Boffito (London, United Kingdom) I02614:00Role and routes of monoclonal antibodies (mAbs) Zain Chagla (Mississauga, Canada) I02714:20Clinical cases discussion Marta Boffito (London, United Kingdom) Zain Chagla (Mississauga, Canada) Krystal Evans (London, United Kingdom) Aruna Subramanian (Stanford, United States) I02814:40Panel discussion and Q&A Krystal Evans (London, United Kingdom) Aruna Subramanian (Stanford, United States) Co-organised with:GSK2232nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS3413:30 - 15:30Integrated SymposiumHall N mRNA science: a paradigm shift to address unmet medical needs ChairRavindra Gupta (London, United Kingdom) ESCMID-appointed chairYazdan Yazdanpanah (Paris, France) I17513:30Welcome and introduction Ravindra Gupta (London, United Kingdom) Yazdan Yazdanpanah (Paris, France) I17613:45mRNA platform technology Melissa Moore (Brookline, United States) I17714:10Understanding adaptive immune responses to COVID-19 vaccines Alessandro Sette (San Diego, United States) I17814:35Advances in vaccinology in response to respiratory viruses and the need for preventive approaches Raúl Ortiz De Lejarazu (Valladolid, Spain) I17915:00Panel discussion and Q&A Ravindra Gupta (London, United Kingdom) Yazdan Yazdanpanah (Paris, France) Co-organised with:Moderna Saturday, 23 April 202223 INTEGRATED SYMPOSIA 32nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS0713:30 - 15:30Integrated Symposium Hall O Building on a strong foundation to address a new era to help protect against pneumococcal disease ChairAntoni Torres (Barcelona, Spain) ESCMID-appointed chairPierre Tattevin (Rennes, France) I02913:30Opening remarks Pierre Tattevin (Rennes, France) Antoni Torres (Barcelona, Spain) I03013:38Changing serotype epidemiology of pneumococcal disease in Europe Mario Ramirez (Lisbon, Portugal) I03114:08What can we learn from the PCV experience to date? Charles Feldman (Johannesburg, South Africa) I03214:38Addressing a new era to help protect against pneumococcal disease in adults Wendy Watson (Collegeville, United States) I03315:08Pneumococcal panel discussion and Q&A Antoni Torres (Barcelona, Spain) I03415:28Closing remarks Pierre Tattevin (Rennes, France) Antoni Torres (Barcelona, Spain) Co-organised with: Pfizer Saturday, 23 April 20222432nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE Saturday, 23 April 2022 IS0813:30 - 15:30Integrated Symposium Hall P COVID-19 vaccines: lessons learnt and prospects in 2022 ChairLinda-Gail Bekker (Cape Town, South Africa) ESCMID-appointed chairMichael Dalager-Pedersen (Aalborg, Denmark) I03513:30Welcome and introduction Linda-Gail Bekker (Cape Town, South Africa) Michael Dalager-Pedersen (Aalborg, Denmark) I03613:35COVID-19 immunity: going beyond neutralising antibodies Wendy Burgers (South Africa) I03713:55Correlates of immunity: vaccine efficacy trials of the future TBA I03814:15Transitioning from pandemic to endemic: what is the role of natural immunity? Javier Diez-Domingo (Valencia, Spain) I03914:35Do more variants mean more boosting? Where do we go from here? Ravindra Gupta (United Kingdom) I04014:55Scientific exchange and Q&A Linda-Gail Bekker (Cape Town, South Africa) Michael Dalager-Pedersen (Aalborg, Denmark) Co-organised with: Janssen Pharmaceuticals25 INTEGRATED SYMPOSIA 32nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE Saturday, 23 April 2022 IS0916:15 - 18:15Integrated Symposium Hall L Best of both worlds: maximising serotype coverage and quality of immune responses for pneumococcal disease prevention ChairPaolo Bonanni (Florence, Italy) ESCMID-appointed chairHanna M. Nohynek (Helsinki, Finland) I04116:15Welcome and introduction Paolo Bonanni (Florence, Italy) Hanna M. Nohynek (Helsinki, Finland) I04216:25Pneumococcal disease burden in at- and high-risk adults Mathias Pletz (Jena, Germany) I04316:50Addressing pneumococcal disease burden in at- and high-risk adults with higher-valent pneumococcal vaccines: safety and immunogenicity of PCV15 in at-risk and immunocompromised adults Ulrike Buchwald (North Wales, United States) I04417:30Vaccine policy recommendations to optimize pneumococcal disease prevention in at/high-risk adults: is simplification achievable? Paolo Bonanni (Florence, Italy) I04517:55Discussion and Q&A Paolo Bonanni (Florence, Italy) Hanna M. Nohynek (Helsinki, Finland) Co-organised with: MSD2632nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS1016:15 - 18:15Integrated Symposium Hall M MDR Gram-negative infections in a pandemic world: contemporary treatment options ChairBéatrice Grabein (Munich, Germany) ESCMID-appointed chairRobert A. Bonomo (Cleveland, United States) I04616:15Welcome and introduction Robert A. Bonomo (Cleveland, United States) Béatrice Grabein (Munich, Germany) I04716:20How has the response to the pandemic impacted antimicrobial resistance? Camilla Rodrigues (Mumbai, India) I04816:35Where is the place for polymyxins and carbapenems in the antibiotic armamentarium? George L. Daikos (Athens, Greece) I04916:50When should the contemporary treatment option be used in the critically ill patients? Carolina Garcia-Vidal (Barcelona, Spain) I05017:05In treating multi-drug resistant Pseudomonas aeruginosa infections, what current and future perspectives should we be aware of? Emanuele Durante-Mangoni (Naples, Italy) I05117:20Are all β -lactam/ β -lactamase inhibitors the same when it comes to treating infections complicated by carbapenem-resistant Enterobacterales? George L. Daikos (Athens, Greece) I05217:35What is the importance of real-world evidence in the antibiotic armamentarium? David Paterson (Brisbane, Australia) I05317:50Panel discussion and Q&A Robert A. Bonomo (Cleveland, United States) Béatrice Grabein (Munich, Germany) I05418:10Summary and close Robert A. Bonomo (Cleveland, United States) Béatrice Grabein (Munich, Germany) Co-organised with: Pfizer Saturday, 23 April 202227 INTEGRATED SYMPOSIA 32nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS1116:15 - 18:15Integrated Symposium Hall O Changing microbiology: focus to critical infectious diseases by state-of-art technologies ChairEvgeny A. Idelevich (Greifswald, Germany) ESCMID-appointed chairBelen Rodriguez-Sanchez (Madrid, Spain) I05516:15Welcome and introduction Evgeny A. Idelevich (Greifswald, Germany) Belen Rodriguez-Sanchez (Madrid, Spain) I05616:25MicrobeNet International: building pathogen identification capacity worldwide John Mcquinston (Decatur, United States) I05716:50Phenotypic detection of colistin resistance - new approaches Oscar Ekelund (Växjö, Sweden) I05817:15Drug resistant TB: bridging the gap between treatment regimens and diagnostics Margaretha De Vos (Geneva, Switzerland) I05917:40Exploiting state-of-the-art technologies to take infectious disease diagnostics and hygiene control to the next level Markus Kostrzewa (Bremen, Germany) I06018:05Panel discussion and Q&A Evgeny A. Idelevich (Greifswald, Germany) Belen Rodriguez-Sanchez (Madrid, Spain) Co-organised with:Bruker Daltonics GmbH & Co. KG Saturday, 23 April 20222832nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS1216:15 - 18:15Integrated Symposium Hall P Expected impact on clinical outcomes of early identification and early management of MDR Gram-negative infections ChairEvangelos Giamarellos-Bourboulis (Athens, Greece) ESCMID-appointed chairPranita Tamma (Baltimore, United States) I06116:15Welcome and introduction Evangelos Giamarellos-Bourboulis (Athens, Greece) Pranita Tamma (Baltimore, United States) I06216:25Critical priority bacteria under the spotlight: CRE-KPC Souha S. Kanj (Beirut, Lebanon) I06316:55CRE-KPC management: lessons learned from Italy Marco Falcone (Pisa, Italy) I06417:25Time matters: early vs. late treatment Ryan Schields (Pittsburg, United States) I06517:55Panel discussion and Q&A Evangelos Giamarellos-Bourboulis (Athens, Greece) Pranita Tamma (Baltimore, United States) Co-organised with:Menarini Group Saturday, 23 April 202229 INTEGRATED SYMPOSIA 32nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE Saturday, 23 April 2022 IS1316:15 - 18:15Integrated Symposium Hall Q The usefulness of various point-of-care tests against evolving COVID-19 ChairTBA ESCMID-appointed chairTBA INT316:15Welcome and introduction TBA TBA INT3017:25Use in emergency routine of a new MDx PoCT systems Carlo Federico Perno (Rome, Italy) INT3117:55Performance comparison between MDx PoCT systems and RT-PCR Alexander Domnich (Genoa, Italy) INT3218:25Assessing SARS-CoV-2 neutralizing antibodies after BNT162b2 vaccination and their correlation with SARS-CoV-2 IgG anti-S1, anti-RBD and anti-S2 serological titers Angélica Ramos (Potro, Portugal) INT33 17:55Panel discussion and Q&A TBA TBA Co-organised with:SD BiosensorNext >